Northrop Grumman (NOC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Northrop Grumman (NOC) reported Q2 2025 revenue of $10.35 billion, a 1.3% year-over-year increase that surpassed consensus estimates by 2.94%, alongside EPS of $7.11, beating the $6.71 consensus by 5.96%. Key segment performance was mixed, with Defense Systems sales surging 31.6% to $1.99 billion and Mission Systems sales up 13.9% to $3.16 billion, while Space Systems sales declined 25.9% to $2.65 billion. Despite the earnings beat, NOC shares have returned 3.1% over the past month, underperforming the S&P 500's 5.9% gain, and the stock currently holds a Zacks Rank #4 (Sell), indicating potential near-term underperformance.

Analysis

Northrop Grumman (NOC) reported a mixed but ultimately positive Q2 2025, surpassing consensus estimates on both revenue and earnings. Total revenue reached $10.35 billion, a 2.94% beat driven by a modest 1.3% year-over-year increase, while EPS of $7.11 represented a more significant 5.96% surprise. A deeper look at segment performance reveals a sharp divergence. The Defense Systems division was the standout performer, with sales surging 31.6% year-over-year to $1.99 billion, handily beating estimates. Mission Systems also posted strong results, with a 13.9% year-over-year sales increase to $3.16 billion, also above expectations. However, this strength was significantly offset by the Space Systems segment, which saw a substantial 25.9% year-over-year decline in sales to $2.65 billion, missing analyst forecasts. Aeronautics Systems delivered modest 5.1% sales growth but also slightly missed revenue targets. Despite the overall earnings beat, the stock's recent performance of +3.1% has lagged the S&P 500 composite's +5.9% gain, suggesting investor concern over the underlying segment weakness, a sentiment reinforced by its current Zacks Rank #4 (Sell) designation.

Key Decisions for Investors

• Investors should look beyond the headline earnings beat and focus on the significant performance divergence across segments, particularly the material 25.9% year-over-year revenue contraction in the Space Systems division.
• While the exceptional growth in Defense Systems (+31.6%) and Mission Systems (+13.9%) provides a strong base, the stock's recent underperformance and the Zacks #4 (Sell) rating signal that near-term headwinds may cap upside potential.
• It is critical to seek further clarity on the outlook for the Space Systems segment, as its recovery or continued decline will likely be a primary catalyst for the stock's future direction.
• Consider trimming exposure or hedging positions given the conflicting signals of a top-line beat against a major segment's decline and an explicit 'Sell' rating from the reporting source.